The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Endothelial Nitric Oxide Synthase in Vascular Disease: From Marvel to Menace
Abstract
Nitric oxide (NO·) is an important protective molecule in the vasculature, and endothelial NO· synthase (eNOS) is responsible for most of the vascular NO· produced. A functional eNOS oxidizes its substrate l -arginine to l -citrulline and NO·. This normal function of eNOS requires dimerization of the enzyme, the presence of the substrate l -arginine, and the essential cofactor (6 R )-5,6,7,8-tetrahydro- l -biopterin (BH 4 ), one of the most potent naturally occurring reducing agents. Cardiovascular risk factors such as hypertension, hypercholesterolemia, diabetes mellitus, or chronic smoking stimulate the production of reactive oxygen species in the vascular wall. Nicotinamide adenine dinucleotide phosphate (NADPH) oxidases represent major sources of this reactive oxygen species and have been found upregulated and activated in animal models of hypertension, diabetes, and sedentary lifestyle and in patients with cardiovascular risk factors. Superoxide (O 2 · − ) reacts avidly with vascular NO· to form peroxynitrite (ONOO − ). The cofactor BH 4 is highly sensitive to oxidation by ONOO − . Diminished levels of BH 4 promote O 2 · − production by eNOS (referred to as eNOS uncoupling). This transformation of eNOS from a protective enzyme to a contributor to oxidative stress has been observed in several in vitro models, in animal models of cardiovascular diseases, and in patients with cardiovascular risk factors. In many cases, supplementation with BH 4 has been shown to correct eNOS dysfunction in animal models and patients. In addition, folic acid and infusions of vitamin C are able to restore eNOS functionality, most probably by enhancing BH 4 levels as well.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The uncoupling causes eNOS activity to change from healthy (producing NO) to toxic (generating superoxide) (303).”
From Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation (2019) · cites this paper as [303]
In the citing paper
“Similarly, vascular disease, cardiovascular disease (CVD), and metabolic syndrome all share effective loss of NO function[23,35–39].”
From Enterosalivary nitrate metabolism and the microbiome: Intersection of microbial metabolism, nitric oxide and diet in cardiac and pulmonary vascular health (2017) · cites this paper as [23]
Citations
Cites
NAD(P)H Oxidase: Role in Cardiovascular Biology and Disease
Griendling, K. K., Sorescu, D., & Ushio-Fukai, M. (2000) · Circulation Research · doi:10.1161/01.res.86.5.494 · Cited by 2,886
Rajagopalan, S., Kurz, S. D., Münzel, T. F., Tarpey, M. M., Freeman, B. Α., Griendling, K. K., & Harrison, D. G. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118623 · Cited by 2,466
Heitzer, T., Schlinzig, T., Krohn, K., Meinertz, T., & Münzel, T. (2001) · Circulation · doi:10.1161/hc4601.099485 · Cited by 1,961
Hypercholesterolemia increases endothelial superoxide anion production.
Ohara, Y., Peterson, T. E., & Harrison, D. G. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116491 · Cited by 1,765
Landmesser, U., Dikalov, S., Price, S. R., McCann, L., Fukai, T., Holland, S. M., Mitch, W. E., & Harrison, D. G. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200314172 · Cited by 1,660
Landmesser, U., Dikalov, S., Price, S. R., McCann, L. A., Fukai, T., Holland, S. M., Mitch, W. E., & Harrison, D. G. (2003) · Journal of Clinical Investigation · doi:10.1172/jci14172 · Cited by 1,652
Mechanisms Underlying Endothelial Dysfunction in Diabetes Mellitus
Hink, U., Li, H., Mollnau, H., Oelze, M., Matheis, E., Hartmann, M., Skatchkov, M. P., Thaiss, F., Stahl, R. A. K., Warnholtz, A., et al. (2001) · Circulation Research · doi:10.1161/01.res.88.2.e14 · Cited by 1,190
Nitric oxide synthase isozymes. Characterization, purification, molecular cloning, and functions.
Förstermann, U., Closs, E. I., Pollock, J. S., Nakane, M., Schwarz, P., Gath, I., & Kleinert, H. (1994) · Hypertension · doi:10.1161/01.hyp.23.6.1121 · Cited by 1,110
Pollock, J. S., Förstermann, U., Mitchell, J. A., Warner, T. D., Schmidt, H. H. H. W., Nakane, M., & Murad, F. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.23.10480 · Cited by 979
Ting, H. H., Timimi, F. K., Boles, K., Creager, S. J., Ganz, P., & Creager, M. A. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118394 · Cited by 869
Flagged first, then by citations
Research works printed but not linked: 23
- 10.1161/res.86.3.347 · DOI
- Li H Witte K August M Brausch I Gödtel-Armbrust U Habermeier A Closs EI Oelze M Münzel T Förstermann U. Reversal of eNOS uncoupling and upregulation of eNOS expression lowers blood pressure in hypertensive rats. J Am Coll Cardiol. In press.
- 10.1161/res.88.2.e14 · DOI
- 10.1161/circ.99.15.2027 · DOI
- 10.1161/res.86.5.494 · DOI
- 10.1161/circ.94.11.2756 · DOI
- 10.1161/circ.101.11.1261 · DOI
- 10.1161/circ.100.21.2131 · DOI
- 10.1161/hyp.30.1.57 · DOI
- 10.1161/res.77.3.510 · DOI
- 10.1161/circ.103.9.1282 · DOI
- 10.1161/hyp.33.6.1353 · DOI
- 10.1161/res.86.1.e7 · DOI
- 10.1161/res.86.2.e36 · DOI
- 10.1161/circ.104.10.1119 · DOI
- 10.1161/res.87.2.99 · DOI
- 10.1161/res.87.7.566 · DOI
- 10.1161/hyp.38.5.1044 · DOI
- 10.1161/circ.104.22.2673 · DOI
- 10.1161/circ.94.1.6 · DOI
- 10.1161/circ.97.3.237 · DOI
- 10.1161/atvb.22.1.6 · DOI
- 10.1161/atvb.20.1.185 · DOI
Cited by
Sorted by citations
Items 301–400 of 1,003
Cardiovascular and metabolic effects of Berberine
Affuso, F. (2010) · World Journal of Cardiology · doi:10.4330/wjc.v2.i4.71 · Cited by 94
Vadivel, A., Aschner, J. L., Rey-Parra, G., Magarik, J. A., Zeng, H., Summar, M. L., Eaton, F., & Thébaud, B. (2010) · Pediatric Research · doi:10.1203/pdr.0b013e3181f90278 · Cited by 94
“In addition to NO production, an adequate supply of precursor molecule is necessary to maintain the NOS complex in its “coupled” state (23).”
Fleißner, F., & Thum, T. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3502 · Cited by 96
“In the diabetic vascular system, eNOS uncoupling may occur with the consequence that eNOS switches its NO production to release of ROS which in turn can react with NO to the vascular toxicant peroxynitrite (26, 27).”
Vascular Actions of Nitric Oxide as Affected by Exposure to Alcohol
Toda, N., & Ayajiki, K. (2010) · Alcohol and Alcoholism · doi:10.1093/alcalc/agq028 · Cited by 92
“participates in many cardiovascular diseases, including hypertension, stroke, coronary heart diseases and atherosclerosis (Yetik-Anacak and Catravas, 2006; Förstermann and Münzel, 2006; Liu and Huang, 2008).”
BackgroundRegulation of Lymphocytes by Nitric Oxide
Bogdan, C. (2010) · Methods in molecular biology · doi:10.1007/978-1-60761-869-0_24 · Cited by 95
Cardiovascular Adaptations to Exercise Training
Hellsten, Y., & Nyberg, M. (2016) · Comprehensive physiology · doi:10.1002/j.2040-4603.2016.tb00672.x · Cited by 92
Redox implications in adipose tissue (dys)function-A new look at old acquaintances
Jankovic, A., Korac, A., Buzadzic, B., Otasevic, V., Stancic, A., Daiber, A., & Korac, B. (2015) · Redox Biology · doi:10.1016/j.redox.2015.06.018 · Cited by 91
“to O2 in NAD(P)H-dependent reactions [133,134].”
The inflammatory protein Pentraxin 3 in cardiovascular disease
Fornai, F., Carrizzo, A., Forte, M., Ambrosio, M., Damato, A., Ferrucci, M., Biagioni, F., Busceti, C. L., Puca, A. A., & Vecchione, C. (2016) · Immunity & Ageing · doi:10.1186/s12979-016-0080-1 · Cited by 91
“The impairment of the nitric oxide pathway and the enhanced smooth muscle vasoconstriction represent the main mechanisms leading to endothelial dysfunction in hypertension [35, 36].”
BackgroundRegulatory Mechanisms of the Wnt/β-Catenin Pathway in Diabetic Cutaneous Ulcers
Zhang, H., Nie, X., Shi, X., Zhao, J., Chen, Y., Yao, Q.-Y., Sun, C., & Yang, J. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01114 · Cited by 91
“Sustained hyperglycemia results in the dysfunction of epithelial cells, leading to a decrease in pro-angiogenic signaling and nitric oxide (NO) production (Förstermann and Münzel, 2006).”
BackgroundDietary flavanols improve cerebral cortical oxygenation and cognition in healthy adults
Gratton, G., Weaver, S. R., Burley, C. V., Low, K. A., Maclin, E. L., Johns, P. W., Pham, Q. S., Lucas, S. J. E., Fabiani, M., & Rendeiro, C. (2020) · Scientific Reports · doi:10.1038/s41598-020-76160-9 · Cited by 91
Wohlfart, P., Xu, H., Endlich, A., Habermeier, A., Closs, E. I., Hübschle, T., Mang, C. F., Strobel, H., Suzuki, T. C., Kleinert, H., et al. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.128009 · Cited by 91
“Supplementation with BH4 is capable of correcting eNOS dysfunction in several types of pathophysiology (Förstermann and Munzel, 2006).”
BackgroundInfluentialAntithrombotic Effect and Mechanism of Radix Paeoniae Rubra
Xie, P., Cui, L., Shan, Y., & Kang, W. (2017) · BioMed Research International · doi:10.1155/2017/9475074 · Cited by 90
“And the activation of eNOS promotes the continued release of NO [26, 27].”
BackgroundTyml, K. (2010) · Microcirculation · doi:10.1111/j.1549-8719.2010.00080.x · Cited by 90
“, by preventing BH4 oxidation), increased eNOS-derived NO in these cells [17,32,72], reduced Pselectin protein expression [3,11], and reduced platelet adhesion [58,65,75].”
BackgroundInfluentialRole of Arginase in Vessel Wall Remodeling
Durante, W. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00111 · Cited by 94
“Aside from serving as a substrate, l-arginine plays an important structural and functional role by facilitating the intracellular assembly of the dimeric form of NOS and the proper coupling between the oxidative and reductive domains of the enzyme (Baek et al., 1993; Forstermann and Munzel, 2006).”
BackgroundTyml, K., Li, F., & Wilson, J. X. (2008) · Critical Care Medicine · doi:10.1097/ccm.0b013e31818024f6 · Cited by 89
“2) suggested that BH4 may be oxidized during sepsis and that the restorative effect of ascorbate may be achieved through the maintenance of BH4 in the reduced state required for it to function as a cofactor of eNOS (42, 43).”
BackgroundEffect of Nitrous Oxide Anesthesia on Plasma Homocysteine and Endothelial Function
Myles, P. S., Chan, M. T. V., Kaye, D. M., McIlroy, D. R., Lau, C. W., Symons, J. A., & Chen, S. (2008) · Anesthesiology · doi:10.1097/aln.0b013e31818629db · Cited by 90
“It seems likely that, as others have suggested,(21) there is individual variability in the effects of homocysteine on endothelial oxidative pathways.(20) We could not identify any substantial effect of nitrous oxide or surgery on ADMA concentration alone.”
BackgroundInfluentialBlekkenhorst, L. C., Bondonno, N. P., Liu, A. H., Ward, N. C., Prince, R. L., Lewis, J. R., Devine, A., Croft, K. D., Hodgson, J. M., & Bondonno, C. P. (2018) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqx046 · Cited by 89
Maloney-Hinds, C., PETROFSKY, J. S., Zimmerman, G. J., & Hessinger, D. A. (2009) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2008.0011 · Cited by 89
Heiß, E. H., Schachner, D., Werner, E. R., & Dirsch, V. M. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.009175 · Cited by 89
Hydrogen Sulfide and Endothelial Dysfunction: Relationship with Nitric Oxide
Altaany, Z., Moccia, F., Munaron, L., Mancardi, D., & Wang, R. (2014) · Current Medicinal Chemistry · doi:10.2174/0929867321666140706142930 · Cited by 86
“common mechanisms for eNOS regulation as shown in Table 1 [66].”
Patel, S. (2020) · IJC Heart & Vasculature · doi:10.1016/j.ijcha.2020.100595 · Cited by 84
“Thus, reduced bioavailability of NO from superoxide-forming XO and its correlates remain a likely pathway for endothelial dysfunction and vascular stiffness [38,39].”
BackgroundSanayama, Y., Nagasaka, H., Takayanagi, M., Ohura, T., Sakamoto, O., Ito, T., Ishige-Wada, M., Usui, H., Yoshino, M., Ohtake, A., et al. (2011) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2011.03.019 · Cited by 87
Wang, X., Xu, X. J., Tao, W., Li, Y., Wang, Y., & Yang, L. (2012) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2012/519031 · Cited by 85
“For examples, NO is an important protective molecule in the vasculature, and endothelial nitric-oxide synthase (P5) is responsible for most of the vascular NO [72].”
BackgroundLoss of DGKε induces endothelial cell activation and death independently of complement activation
Bruneau, S., Néel, M., Roumenina, L. T., Frimat, M., Laurent, L., Frémeaux‐Bacchi, V., & Fakhouri, F. (2014) · Blood · doi:10.1182/blood-2014-06-579953 · Cited by 86
Identifying Common Genetic Risk Factors of Diabetic Neuropathies
Witzel, I., Jelinek, H. F., Khalaf, K. A., Lee, S., Khandoker, A. H., & AlSafar, H. S. (2015) · Frontiers in Endocrinology · doi:10.3389/fendo.2015.00088 · Cited by 89
Vermeulen, M. A. R., van de Poll, M. C. G., Ligthart‐Melis, G. C., Dejong, C. H. C., van den Tol, M. P., Boelens, P. G., & van Leeuwen, P. A. M. (2007) · Critical Care Medicine · doi:10.1097/01.ccm.0000278600.14265.95 · Cited by 86
“This may be due to its capacity to highly react with superoxide, a free radical produced in the vascular wall by cellular oxidases that react with NO by forming peroxynitrate (19).”
BackgroundPlatelet in thrombo-inflammation: Unraveling new therapeutic targets
Sharma, S. H., Tyagi, T., & Antoniak, S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1039843 · Cited by 92
The ubiquitin-proteasome pathway and endothelial (dys)function
Stangl, K., & Stangl, V. (2009) · Cardiovascular Research · doi:10.1093/cvr/cvp315 · Cited by 89
eNOS Haplotypes Associated with Gestational Hypertension or Preeclampsia
Sandrim, V. C., Palei, A. C., Cavalli, R. D. C., Araujo, F. M., Ramos, E. S., Duarte, G. G., & Tanus-Santos, J. E. (2008) · Pharmacogenomics · doi:10.2217/14622416.9.10.1467 · Cited by 87
The nitric oxide-guanylate cyclase pathway and glaucoma
Wareham, L. K., Buys, E. S., & Sappington, R. M. (2018) · Nitric Oxide · doi:10.1016/j.niox.2018.04.010 · Cited by 85
Mason, R. P., Dawoud, H., Jacob, R. F., Sherratt, S. C. R., & Maliñski, T. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.04.118 · Cited by 87
Endothelial dysfunction in neuroprogressive disorders—causes and suggested treatments
Morris, G., Puri, B. K., OLIVE, L. S., Carvalho, A. F., Berk, M., Walder, K. R., Gustad, L. T., & Maes, M. H. J. (2020) · BMC Medicine · doi:10.1186/s12916-020-01749-w · Cited by 88
Zhu, H.-Y., Hong, F.-F., & Yang, S.-L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094540 · Cited by 84
Role of Rutin on Nitric Oxide Synthesis in Human Umbilical Vein Endothelial Cells
Ugusman, A., Zakaria, Z., Chua, K. H., Nordin, N. A. M. M., & Mahdy, Z. A. (2014) · The Scientific World JOURNAL · doi:10.1155/2014/169370 · Cited by 84
“Endothelial nitric oxide synthase (eNOS) is the major enzyme responsible for NO production in the blood vessels [3].”
BackgroundNitric-Oxide Supplementation for Treatment of Long-Term Complications in Argininosuccinic Aciduria
Nagamani, S. C. S., Campeau, P. M., Shchelochkov, O. A., Premkumar, M. H., Guse, K., Brunetti‐Pierri, N., Chen, Y., Sun, Q., Tang, Y., Palmer, D. J., et al. (2012) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2012.03.018 · Cited by 82
Therapeutic Potential of Tetrahydrobiopterin for Treating Vascular and Cardiac Disease
Moens, A. L., & Kass, D. A. (2007) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e318123f854 · Cited by 83
Diesel exhaust exposure enhances venoconstriction via uncoupling of eNOS
Knuckles, T. L., Lund, A. K., Lucas, S., & Campen, M. J. (2008) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2008.03.010 · Cited by 83
Gasotransmitter Heterocellular Signaling
Kolluru, G. K., Shen, X., Yuan, S. S., & Kevil, C. G. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2016.6909 · Cited by 83
“However, the predominant mechanism of NO production is through nitric oxide synthases (NOSs)— neuronal (NOS 1), inducible (NOS 2), and endothelial (NOS 3) (64).”
BackgroundMechanisms of endothelial dysfunction in obesity-associated hypertension
Lobato, N. S., Filgueira, F. P., Akamine, E. H., Tostes, R. C., de Carvalho, M. H. C., & Fortes, Z. B. (2012) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2012007500058 · Cited by 84
“The crucial role of uncoupled eNOS as a O2- producing enzyme has been reported in hypertension (19) and diabetes (20).”
BackgroundActivation and inflammation of the venous endothelium in vein graft disease
Ward, A. O., Caputo, M., Angelini, G. D., George, S. J., & Zakkar, M. (2017) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2017.08.023 · Cited by 88
“The dysregulation of NO balance has profound effects for the vascular wall, particu larly in the context of the vein graft, with the tipping of this balance to reduced NO availability and increased ROS production, in particular, superoxide (O2 ) generation, primarily through eNOS uncoupling by combined actions of NADP…”
BackgroundRacial disparities in cardiovascular disease risk: mechanisms of vascular dysfunction
Brothers, R. M., Fadel, P. J., & Keller, D. M. (2019) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00126.2019 · Cited by 82
“The mechanisms leading to reduced NO bioavailability are multifactorial; however, uncoupling of endothelial NO synthase (eNOS) plays a significant role (32, 40, 56, 130, 134).”
BackgroundHahad, O., Frenis, K., Kuntić, M., Daiber, A., & Münzel, T. F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052419 · Cited by 86
“The state of eNOS plays an important role in whether it produces a vascular hero, •NO, or a villain, O2 [98].”
BackgroundReactive Oxygen Species and Endothelial Ca2+ Signaling: Brothers in Arms or Partners in Crime?
Negri, S., Faris, P. S., & Moccia, F. D. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22189821 · Cited by 90
“First, NOS hydroxylates L-arginine to Nω-hydroxy-L-arginine; then, it oxidates Nω-hydroxy-L-arginine to L-citrulline and NO [86].”
BackgroundRoles of Nitric Oxide in the Regulation of Reproduction: A Review
Luo, Y., Zhu, Y., Basang, W., Wang, X., Li, C., & Zhou, X. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.752410 · Cited by 83
The Mechanisms of Restenosis and Relevance to Next Generation Stent Design
Clare, J., Ganly, J., Bursill, C. A., Sümer, H., Kingshott, P., & de Haan, J. B. (2022) · Biomolecules · doi:10.3390/biom12030430 · Cited by 85
Tobacco smoking and vascular biology and function: evidence from human studies
Hahad, O., Kuntić, M., Kuntić, I., Daiber, A., & Münzel, T. F. (2023) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-023-02805-z · Cited by 91
“Thus, eNOS can be considered as an enzyme with two faces [20].”
BackgroundThe molecular sources of reactive oxygen species in hypertension
Puddu, P., Puddu, G. M., Cravero, E., Rosati, M., & Muscari, A. (2008) · Blood Pressure · doi:10.1080/08037050802029954 · Cited by 82
Endothelium and cardiopulmonary resuscitation
Adams, J. A. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000246012.68479.49 · Cited by 82
Hyperglycemia in stroke and possible treatments
Li, W. A., Moore-Langston, S., Chakraborty, T., Rafols, J. A., Conti, A. C., & Ding, Y. (2013) · Neurological Research · doi:10.1179/1743132813y.0000000209 · Cited by 82
Drouin, A., Thorin‐Trescases, N., Hamel, É., Falck, J. R., & Thorin, É. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.10.005 · Cited by 82
“On the other hand, our findings are in contrast with the eNOS-dependent generation of O2 , which has only been observed in pathological states [26].”
Cheng, Z. A., Jiang, X., Pansuria, M., Fang, P., Mai, J., Mallilankaraman, K. B., Gandhirajan, R. K., Eguchi, S., Scalia, R. G., Madesh, M., et al. (2014) · Diabetes · doi:10.2337/db14-0784 · Cited by 82
Harding, I. C., Mitra, R., Mensah, S. A., Herman, I. M., & Ebong, E. E. (2018) · Journal of Translational Medicine · doi:10.1186/s12967-018-1721-2 · Cited by 81
Sawada, N., & Liao, J. K. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5524 · Cited by 81
“Also, ROCK inhibition in healthy individuals might lead to an excess of NO production, resulting in the formation of peroxynitrite, and this could lead to eNOS uncoupling and worsening endothelial function (36).”
BackgroundVasdev, S., Gill, V. D., & Singal, P. K. (2007) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-007-0039-0 · Cited by 82
“Alteration to these residues of BH4 results in an ‘‘uncoupling’’ of eNOS which decreases NO bioavailability and increases oxidative stress [166, 169, 172].”
BackgroundDetection of Hydrogen Peroxide with Fluorescent Dyes
Rezende, F., Brandes, R. P., & Schröder, K. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7401 · Cited by 81
“Under resting conditions, (cid:2) O 2 - mainly appears as a by-product of enzymatic reactions involving cytochrome P450, mitochondrial complexes I (NADH:ubiquinone oxidoreductase) and III (ubiquinol:cytochrome c oxidoreductase), xanthine/XO, and nitric oxide (NO) synthase (44, 94).”
Atherosclerotic Calcification: Wnt Is the Hint
Albanese, I., Khan, K., Barratt, B., Kindi, H. N. A., & Schwertani, A. G. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.117.007356 · Cited by 88
“Under normal circumstances, endothelial cells (ECs) release an array of vasodilators and anticoagulants, such as NO and prostacyclin, which reduce platelet aggregation, monocyte and leukocyte adhesion, and VSMC proliferation.(13) Under pathological conditions, ECs release factors, such as thromboxane and endothelin-1,…”
BackgroundMaiuolo, J., Gliozzi, M., Musolino, V., Carresi, C., Nucera, S., Macrì, R., Scicchitano, M., Bosco, F., Scarano, F., Ruga, S., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20123022 · Cited by 87
“On the other hand, it is well known that an impairment of NO release leads to the so-called endothelial dysfunction [24].”
BackgroundMatters of the heart: Cellular sex differences
Walker, C. J., Schroeder, M. E., Aguado, B. A., Anseth, K. S., & Leinwand, L. A. (2021) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2021.04.010 · Cited by 74
Steinkamp-Fenske, K., Bollinger, L., Xu, H., Yao, Y., Horke, S., Förstermann, U., & Li, H. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.123356 · Cited by 81
“Oxidation of BH4 due to NADPH oxidase-mediated vascular oxidative stress may represent a major cause of BH4 deficiency in many cases (Förstermann and Munzel, 2006).”
BackgroundInfluentialJuni, R. P., Al‐Shama, R., Kuster, D. W. D., van der Velden, J., Hamer, H. M., Vervloet, M. G., Eringa, E. C., Koolwijk, P., & van Hinsbergh, V. W. M. (2020) · Kidney International · doi:10.1016/j.kint.2020.12.013 · Cited by 79
Endothelial Dysfunction in the Pathogenesis of Abdominal Aortic Aneurysm
DeRoo, E., Stranz, A., Yang, H. M., Hsieh, M. L., Se, C., & Zhou, T. (2022) · Biomolecules · doi:10.3390/biom12040509 · Cited by 82
Siow, R., & Churchman, A. T. (2007) · Cardiovascular Research · doi:10.1016/j.cardiores.2007.06.007 · Cited by 80
“For example, eNOS gene delivery to the adventitia [71] may result in uncoupling of the enzyme to generate deleterious superoxide under certain conditions [107].”
BackgroundWare, L. B., Magarik, J. A., Wickersham, N. E., Cunningham, G. R., Rice, T. W., Christman, B. W., Wheeler, A. P., Bernard, G. R., & Summar, M. L. (2013) · Critical Care · doi:10.1186/cc11934 · Cited by 78
“When uncoupled, NOS preferentially catalyzes the production of superoxide ion from reduction of molecular oxygen rather than NO [17].”
BackgroundRole of Hyperhomocysteinemia and Hyperuricemia in Pathogenesis of Atherosclerosis
Zhao, J., Chen, H., Liu, N., Chen, J., Gu, Y., Chen, J., & Yang, K. (2017) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2016.10.012 · Cited by 87
Ginkgo biloba extract EGb® 761 increases endothelial nitric oxide production in vitro and in vivo
Koltermann, A., Hartkorn, A., Koch, E., Fürst, R., Vollmar, A. M., & Zahler, S. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-7085-z · Cited by 80
Vascular cognitive impairment – Past, present, and future challenges
Badji, A., Youwakim, J., Cooper, A., Westman, E., & Marseglia, A. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.102042 · Cited by 84
Molecular Mechanisms of Oxidative Stress in Acute Kidney Injury: Targeting the Loci by Resveratrol
Rashid, H., Jali, A. M., Akhter, M. S., & Abdi, S. A. H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms25010003 · Cited by 91
“Since there is a heterogenous expression of (iNOS), the varying concentrations of NO can cause uneven perfusion [93,94].”
BackgroundEndothelial Dysfunction in Adults with Obstructive Sleep Apnea
(2011) · Advances in cardiology · doi:10.1159/000325108 · Cited by 76
HZE56Fe-Ion Irradiation Induces Endothelial Dysfunction in Rat Aorta: Role of Xanthine Oxidase
Soucy, K. G., Lim, H. K., Kim, J. H., Oh, Y., Attarzadeh, D. O., Sevinc, B., Kuo, M. M., Shoukas, A. A., Vazquez, M. E., & Berkowitz, D. E. (2011) · Radiation Research · doi:10.1667/rr2598.1 · Cited by 77
Oxidative Stress in Cardiovascular Disease
Schnabel, R. B., & Blankenberg, S. (2007) · Circulation · doi:10.1161/circulationaha.107.728394 · Cited by 77
Nrf2 as an Endothelial Mechanosensitive Transcription Factor
McSweeney, S. R., Warabi, E., & Siow, R. C. M. (2015) · Hypertension · doi:10.1161/hypertensionaha.115.06146 · Cited by 78
Histone Deacetylase Inhibitors and Diabetic Kidney Disease
Hadden, M. J., & Advani, A. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19092630 · Cited by 79
“In the setting of hyperglycemia, ROS may react with eNOS-derived nitric oxide (NO) to form peroxynitrite, which can in turn oxidize the eNOS cofactor tetrahydrobiopterin leading to the generation of superoxide in preference to NO [85,86].”
BackgroundKubota, Y., Miyamoto, M., Takagi, G., Ikeda, T., Kirinoki‐Ichikawa, S., Tanaka, K., & Mizuno, K. (2012) · Journal of Korean Medical Science · doi:10.3346/jkms.2012.27.11.1364 · Cited by 76
“Endothelial function is deteriorated by the attenuation of nitric oxide (NO) production (5, 6) and increased NO inactivation (7) in patients with DM.”
BackgroundDzhalilova, D. S., & Makarova, O. V. (2020) · Biomedicines · doi:10.3390/biomedicines8100428 · Cited by 79
The Role of Oxidative Stress in Acute Ischemic Stroke‐Related Thrombosis
Li, Z., Bi, R., Sun, S., Chen, S., Chen, J., Hu, B., & Jin, H. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/8418820 · Cited by 76
Pathogenesis and pathophysiology of accelerated atherosclerosis in the diabetic heart
D’Souza, A., Hussain, M., Howarth, F. C., Woods, N. M., Bidasee, K. R., & Singh, J. (2009) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-009-0148-8 · Cited by 75
“Additionally, NO has been shown to mediate DNA synthesis, mitogenesis, and proliferation of VSMC [116].”
BackgroundDong, Y., Liu, L., Kataoka, K., Nakamura, T., Fukuda, M., Tokutomi, Y., Nako, H., Ogawa, H., & Kim‐Mitsuyama, S. (2009) · Diabetologia · doi:10.1007/s00125-009-1575-5 · Cited by 76
“In this work, we also examined the effect of aliskiren on eNOS, since eNOS counteracts superoxide via the production of nitric oxide, and protects against the impairment of vascular endothelial function [22, 39, 40].”
BackgroundYamamoto, E., Kataoka, K., Shintaku, H., Yamashita, T., Tokutomi, Y., Dong, Y., Matsuba, S., Ichijo, H., Ogawa, H., & Kim‐Mitsuyama, S. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.153692 · Cited by 76
Steinkamp-Fenske, K., Bollinger, L., Völler, N., Xu, H., Yao, Y., Bauer, R., Förstermann, U., & Li, H. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.03.028 · Cited by 75
Gap Junction Protein Cx37 Interacts With Endothelial Nitric Oxide Synthase in Endothelial Cells
Pfenniger, A., Derouette, J.-P., Verma, V., Lin, X., Foglia, B. F., Coombs, W., Roth, I., Satta, N., Dunoyer-Geindre, S., Sorgen, P. L., et al. (2010) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.109.200816 · Cited by 76
Melchiorri, A. J., Bracaglia, L. G., Kimerer, L. K., Hibino, N., & Fisher, J. P. (2016) · Tissue Engineering Part C Methods · doi:10.1089/ten.tec.2015.0562 · Cited by 76
“This protective enzyme contributes to the inhibition of platelet aggregation and adhesion, which mediates inflammation and thrombosis.(35) In addition, VEGF is an essential growth factor for ECs.”
Cardiovascular effects of lead exposure.
Vaziri, N. D., & Gonick, H. C. (2008) · PubMed · Cited by 75
Bench-to-bedside review: Nitric oxide in critical illness – update 2008
Hollenberg, S. M., & Cinel, İ. (2009) · Critical Care · doi:10.1186/cc7706 · Cited by 77
“Also, as noted above, oxidative stress contributes to uncoupling of eNOS, increasing formation of reactive oxygen intermediates [11].”
BackgroundInfluentialEndothelial Nitric Oxide Synthase in Human Intestine Resected for Necrotizing Enterocolitis
Nowicki, P. T., Caniano, D. A., Hammond, S., Giannone, P. J., Besner, G. E., Reber, K. M., & Nankervis, C. A. (2006) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2006.09.029 · Cited by 75
Antoniades, C. A., Cunnington, C., Antonopoulos, A. S., Neville, M., Margaritis, M., Demosthenous, M., Bendall, J. K., Hale, A., Cerrato, R., Tousoulis, D., et al. (2011) · Circulation · doi:10.1161/circulationaha.111.029272 · Cited by 76
“of males) 10 (9) 10 (8) 280 (244) 85 (73) 11 (6) 40 (33) 10 (7) 19 (5)”
Schäfer, A., Fraccarollo, D., Pförtsch, S., Flierl, U., Vogt, C., Pfrang, J., Kobsar, A. L., Renné, T., Eigenthaler, M., Ertl, G., et al. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707459 · Cited by 74
“eNOS becomes uncoupled under certain circumstances such as high glucose challenge to produce superoxide instead of NO (Bauersachs and Schäfer, 2005; Forstermann and Munzel, 2006).”
BackgroundFu, Z., Wu, J., Nesil, T., Li, M. D., Aylor, K. W., & Liu, Z. (2016) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00297.2016 · Cited by 74
“The marked decrease in hippocampal eNOS expression in HFD-fed rats provides further explanation of the lack of microvascular response to insulin in those animals, as eNOS is the major molecule regulating vascular tension (17, 54).”
BackgroundYzydorczyk, C., Armengaud, J.-B., Peyter, A., Chehade, H., Cachat, F., Juvet, C., Siddeek, B., Simoncini, S., Sabatier, F., Dignat‐George, F., et al. (2017) · Journal of Developmental Origins of Health and Disease · doi:10.1017/s2040174417000265 · Cited by 74
Histone methylation and vascular biology
Wei, X., Yi, X., Zhu, X., & Jiang, D. (2020) · Clinical Epigenetics · doi:10.1186/s13148-020-00826-4 · Cited by 78
Endothelial Dysfunction in Primary Aldosteronism
Chen, Z., Tsai, C., Pan, C., Chou, C., Liao, C., Hung, C., Wu, V., Lin, Y., & TAIPAI Study Group (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20205214 · Cited by 74
“NO is synthesized from L-arginine in the presence of cofactors including tetrahydrobiopterin (BH4) via endothelial NO synthase (eNOS), which is an enzyme expressed in endothelial cells [18].”
BackgroundFurieri, L. B., Galán, M., Avendaño, M. S., García‐Redondo, A. B., Aguado, A., Martínez, S. G., Cachofeiro, V., Bartolomé, M. V., Alonso, M. J., Vassallo, D. V., et al. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01203.x · Cited by 73
“However, we cannot discount a possible reduction in the activity of this isoform, or that uncoupled eNOS due to tetrahydrobiopterin (BH4) deficiency might result in a switch from NO to O2 production (Förstermann and Münzel, 2006).”
BackgroundSandrim, V. C., Palei, A. C., Luizon, M. R., Izidoro‐Toledo, T. C., Cavalli, R. D. C., & Tanus-Santos, J. E. (2009) · The Pharmacogenomics Journal · doi:10.1038/tpj.2009.38 · Cited by 74
Sangartit, W., Kukongviriyapan, U., Donpunha, W., Pakdeechote, P., Kukongviriyapan, V., Surawattanawan, P., & Greenwald, S. E. (2014) · PLoS ONE · doi:10.1371/journal.pone.0114908 · Cited by 74
“It is well established that NO produced from endothelial cells possesses diverse bioactivity, including smooth muscle relaxation and vasodilation, antioxidant properties, platelet disaggregation, anti-inflammatory and anti-thrombogenic activity, and the inhibition of cell growth, proliferation and migration [51].”
BackgroundSalden, B. N., Troost, F. J., de Groot, E., Stevens, Y., Garcés‐Rimón, M., Possemiers, S., Winkens, B., & Masclee, A. (2016) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.116.136960 · Cited by 73
Altered Mechanisms of Vasodilation in Aged Human Skin
Holowatz, L. A., Thompson‐Torgerson, C. S., & Kenney, W. L. (2007) · Exercise and Sport Sciences Reviews · doi:10.1097/jes.0b013e3180a02f85 · Cited by 73
“Under circumstances where L-arginine and/or essential cofactors (tetrahydrobiopterin (BH4) are limited, NOS can uncouple to produce superoxide instead of NO (5).”
BackgroundThe Impact of Tobacco Cigarettes, Vaping Products and Tobacco Heating Products on Oxidative Stress
Emma, R., Caruso, M., Campagna, D., Pulvirenti, R., & Volti, G. L. (2022) · Antioxidants · doi:10.3390/antiox11091829 · Cited by 89
“Furthermore, oxidative stress contributes to NOS cofactor tetrahydrobiopterin (BH4) depletion and dimethylarginine dimethylaminohydrolase (an enzyme that degrades dimethylarginase, a potent competitive inhibitor of NOS) inhibition, with a consequent decrease in NO production [105,106].”
BackgroundBuys, E. S., Raher, M. J., Blake, S. L., Neilan, T. G., Graveline, A. R., Passeri, J. J., Llano, M., Pérez-Sanz, T. M., Ichinose, F., Janssens, S. P., et al. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01236.2006 · Cited by 72
“NOS3 is synthesized as monomers and dimerizes in the presence of heme (8).”
BackgroundOng, G. S. Y., & Young, M. J. (2016) · Journal of Molecular Endocrinology · doi:10.1530/jme-15-0318 · Cited by 78
Function and Therapeutic Potential of Mesenchymal Stem Cells in Atherosclerosis
Li, F., Guo, X., & Chen, S. (2017) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2017.00032 · Cited by 72
“Endothelial nitric oxide synthase (eNOS) is responsible for the production of most vascular nitric oxide (NO) (96, 97).”
BackgroundLuo, W., Wang, Y., Yang, H., Dai, C., Hong, H., Li, J., Liu, Z., Guo, Z., Chen, X., He, P., et al. (2018) · Aging · doi:10.18632/aging.101506 · Cited by 72
Metadata
- Authors
- Förstermann, U., & Münzel, T.
- Affiliations
- From the Departments of Pharmacology (U.F.) and Internal Medicine II (Cardiology) (T.M.), Johannes Gutenberg University Hospitals, Mainz, Germany.
- Venue
- Circulation
- Published
- 2006-04-04
- Volume
- 113
- Issue
- 13
- Pages
- 1708-1714
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2146190354
- Cited by
- 1,957
- References
- 67
- Citations by year
- 2026: 93 · 2025: 76 · 2024: 99 · 2023: 86 · 2022: 110 · 2021: 113 · 2020: 110 · 2019: 89 · 2018: 105 · 2017: 105 · 2016: 117 · 2015: 101 · 2014: 123 · 2013: 98 · 2012: 85
- FWCI
- 62.52
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Circulation (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Eicosanoids and Hypertension Pharmacology
- Keywords
- endothelial nitric oxide synthase, nitric oxide, tetrahydrobiopterin, eNOS uncoupling, NADPH oxidase, reactive oxygen species, superoxide, peroxynitrite, oxidative stress, cardiovascular risk factors, hypertension, hypercholesterolemia, diabetes mellitus, smoking, folic acid, vitamin C, L-arginine
- MeSH terms
- Animals, Endothelium, Vascular, Humans, Nitric Oxide, Vascular Diseases, Reactive Oxygen Species, Oxidative Stress, Nitric Oxide Synthase Type III
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review